Download PDF
Synlett 2006(19): 3309-3313  
DOI: 10.1055/s-2006-951555
LETTER
© Georg Thieme Verlag Stuttgart · New York

Gold-Catalyzed Cyclization of O-Propargyl Carbamates under Mild ­Conditions: A Convenient Access to 4-Alkylidene-2-oxazolidinones

Stefanie Ritter, Yoshikazu Horino, Johann Lex, Hans-Günther Schmalz*
University of Cologne, Institute of Organic Chemistry, Greinstr. 4, 50939 Köln, Germany
Fax: +49(221)4703064; e-Mail: schmalz@uni-koeln.de;
Further Information

Publication History

Received 20 July 2006
Publication Date:
23 November 2006 (online)

    Permissions and Reprints All articles of this category

Abstract

On treatment with catalytic amounts of gold(I) chloride (AuCl) and a base co-catalyst, O-propargyl carbamates smoothly undergo a 5-exo-dig cyclization at room temperature to afford 4-methylene-2-oxazolidinones in high yield. Substrates with a sub­stituent at the alkyne terminus stereoselectively give rise to (Z)-4-alkylidene-2-oxazolidinones.

Key words

oxazolidinones - heterocycles - gold catalysis - alkynes

    References and Notes

  • For some leading references, see:
  • 1a Reck F. Zhou F. Girardot M. Kern G. Eyermann CJ. Hales NJ. Ramsay RR. Gravestock MB. J. Med. Chem.  2005,  48:  499 
    CrossrefGoogle Scholar
  • 1b Barbachyn MR. Ford CW. Angew. Chem. Int. Ed.  2003,  42:  2010 ; Angew. Chem. 2003, 115, 2056
    CrossrefGoogle Scholar
  • 1c Kakeya H. Morishita M. Koshino H. Morita T. Kobayashi K. Osada H. J. Org. Chem.  1999,  64:  1052 
    CrossrefGoogle Scholar
  • 2a Ager DJ. Prakash I. Schaad DR. Chem. Rev.  1996,  96:  835 
    Google Scholar
  • 2b Gage JR. Evans DA. Org. Synth.  1990,  68:  83 ; Org. Synth., Coll. Vol. VIII; Wiley: New York, 1993, 339
    Google Scholar
  • 2c Evans DA. Johnson JS. In Comprehensive Asymmetric Catalysis   Vol. III:  Jacobsen EN. Pfaltz A. Yamamoto H. Springer; Berlin, Heidelberg: 1999.  p.1177 
    Google Scholar
  • 3 Shibata I. Kato H. Kanazawa N. Yasuda M. Baba A. J. Am. Chem. Soc.  2004,  126:  466 
    CrossrefGoogle Scholar
  • 4a Shachat N. Bagnell J. J. Org. Chem.  1963,  28:  991 
    CrossrefGoogle Scholar
  • 4b Stoffel PJ. Speziale AJ. J. Org. Chem.  1963,  28:  2814 
    CrossrefGoogle Scholar
  • 5 Müller TE. Beller M. Chem. Rev.  1998,  98:  675 
    Google Scholar
  • 6a Kimura M. Kure S. Yoshida Z. Tanaka S. Fugami K. Tamaru Y. Tetrahedron Lett.  1990,  31:  4887 
    CrossrefGoogle Scholar
  • 6b Tamaru Y. Kimura M. Tanaka S. Kure S. Yoshida Z. Bull. Chem. Soc. Jpn.  1994,  67:  2383 
    CrossrefGoogle Scholar
  • 6c Ohe K. Matsuda H. Ishihara T. Chatani N. Kawasaki Y. Murai S. J. Org. Chem.  1991,  56:  2267 
    CrossrefGoogle Scholar
  • 6d For a related Pd-catalyzed transformation, see: Lei A. Lu X. Org. Lett.  2000,  2:  2699 
    CrossrefGoogle Scholar
  • For recent reviews on Au-catalysis, see:
  • 7a Hashmi ASK. Gold Bull.  2004,  37:  51 
    CrossrefPubMedGoogle Scholar
  • 7b Hashmi ASK. Angew. Chem. Int. Ed.  2004,  44:  6990 ; Angew. Chem. 2005, 117, 7150
    CrossrefPubMedGoogle Scholar
  • 7c Hoffmann-Röder A. Krause N. Org. Biomol. Chem.  2005,  3:  387 
    CrossrefPubMedGoogle Scholar
  • 8a Mizushima E. Hayashi T. Tanaka M. Org. Lett.  2003,  5:  3349 
    CrossrefGoogle Scholar
  • 8b Alfonsi M. Arcadi A. Aschi M. Bianchi G. Marinelli F. J. Org. Chem.  2005,  70:  2265 
    CrossrefGoogle Scholar
  • 8c Gorin DJ. Davis NR. Toste D. J. Am. Chem. Soc.  2005,  127:  11260 
    CrossrefGoogle Scholar
  • 9 Braunstein P. Lehner H. Matt D. Inorg. Synth.  1990,  27:  218 
    Google Scholar
  • For the Au(III)-catalyzed intramolecular hydroamination of simple aminoalkynes, see:
  • 10a Fukuda Y. Utimoto K. Nozaki H. Heterocycles  1987,  25:  297 
    CrossrefGoogle Scholar
  • 10b Fukuda Y. Utimoto K. Synthesis  1991,  975 
    CrossrefGoogle Scholar
  • 10c For the first use of AuCl3 in homogeneous catalysis, see: Hashmi ASK. Schwarz L. Choi J.-H. Frost TM. Angew. Chem. Int. Ed.  2000,  39:  2285 ; Angew. Chem. 2000, 112, 2382
    CrossrefGoogle Scholar
  • 12 Such a mechanism was previously proposed for a related gold-catalyzed transformation (oxazole synthesis): Hashmi ASK. Weyrauch JP. Frey W. Bats JW. Org. Lett.  2004,  6:  4391 
    Google Scholar
  • 14 During the preparation of this manuscript, a method for the gold-catalyzed synthesis of (isomeric) 3-alkylidene-2-oxazolidinones was reported, which nicely complements the work described here: Robles-Machin R. Adrio J. Carretero JC. J. Org. Chem.  2006,  71:  5023 
    CrossrefGoogle Scholar
11

Crystal data for compound 9a: colorless crystals (from cyclohexane); mp 87-88 °C; C16H19NO4S, FW = 321.10, triclinic, space group P-1; a = 7.2854 (2) Å, b = 8.7222 (3) Å, c = 12.7763 (4) Å; α = 96.866 (2)°, β = 100.075 (2)°, γ = 99.598 (2)°; V = 778.85 (4) Å3; Z = 2; d calc = 1.370 g/cm3; R = 0.0391, R w = 0.0837 for 2517 reflections having I > 2σ(I). Further crystallographic data have been deposited at the Cambridge Crystallographic Data Centre. Copies of the data (CCDC 613241) can be obtained free of charge from CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: +44 (1223)336033; e-mail: deposit@ccdc.cam.ac.uk].

13

General Procedure for the AuCl-Catalyzed Cyclization of O -Propargyl Carbamates: To a solution of an O-propargyl carbamate (6 or 8a-8f; 0.5 mmol) and a base co-catalyst (0.025 mol, 5 mol%) in solvent (2 mL) was added AuCl (0.025 mol, 5 mol%). The mixture was stirred at r.t. or 60 °C for the time specified in Tables [2] and [3] . Conversion was monitored by TLC and/or GLC analyses. The reaction mixture was filtered through a small pad of Celite® (elution with CH2Cl2). Removal of the solvent under reduced pressure and purification of the residue by flash chromatog-raphy on SiO2 (cyclohexane-EtOAc, 3:1) afforded the products (7 or 9) as colorless oils or solids.
4-Methylene-3-(toluene-4-sulfonyl)-1-oxa-3-azaspiro[4.5]decan-2-one ( 9a): 1H NMR (300 MHz, CDCl3): δ = 1.34-1.74 (m, 10 H), 2.41 (s, 3 H), 4.39 (d, 2 J = 3 Hz, 1 H, C=CH), 5.46 (d, 2 J = 3 Hz, 1 H, C=CH), 7.31 (d, 3 J = 8.3 Hz, 2 H), 7.89 (d, 3 J = 8.3 Hz, 2 H). 13C NMR (75 MHz, CDCl3): δ = 21.36 (t), 21.65 (q), 24.28 (t), 36.64 (t), 84.83 (s), 90.14 (t), 127.92 (d), 129.75 (d), 134.31 (s), 144.96 (s), 145.94 (s), 150.26 (s). IR (ATR): 1782 (ss, C=O), 1660 (s, C=C) cm-1. MS (DIP-EI, 70 eV): m/z (%) = 321 [M+], 166 (14), 155 (24), 105 (12), 94 (23), 91 (100), 81 (16), 65 (33). HRMS (EI): m/z [M]+ calcd for 12C16H19 14N16O4 32S: 321.1035; found: 321.104.
( Z )-4-Ethylidene-3-tosyloxazolidin-2-one ( 9b): 1H NMR (250 MHz, CDCl3): δ = 1.85 (td, 5 J = 1.8 Hz, 3 J = 7.36 Hz, 3 H, CH3), 2.42 (s, 3 H), 4.62 (app pent, 2 H,), 5.24 (tq, 4 J = 1.8 Hz, 3 J = 7.4 Hz, 1 H), 7.33 (d, 3 J = 8 Hz, 2 H), 7.92 (d, 3 J = 8 Hz, 2 H). Characteristic signals of the minor isomer iso-9b: 1H NMR (250 MHz, CDCl3): δ = 4.56 (dt, 5 J t = 1 Hz, 3 J d = 6 Hz, 2 H), 5.43 (tq, 4 J q = 1 Hz, 3 J t = 5 Hz, 1 H). 13C NMR (75 MHz, CDCl3): δ = 14.63 (q), 21.75 (q), 70.14 (t), 112.43 (q), 128.28 (d), 129.87 (d), 135.4 (s), 138.84 (s), 145.77 (s), 153.54 (s, C=O). IR (ATR): 2923 (w, C=CCH3), 1782 (ss, C=O) cm-1. MS (DIP-EI, 70 eV): m/z (%) = 267 [M+], 155 (34), 112 (11), 95 (32), 91 (100), 65 (23), 57 (44). HRMS (EI): m/z [M]+ calcd for 12C12H13 14N16O4 32S: 267.0565; found: 267.056.
( Z )-4-Benzylidene-3-(toluene-4-sulfonyl)oxazolidin-2-one ( 9c): 1H NMR (250 MHz, CDCl3): δ = 2.42 (s, 3 H), 4.82 (d, 4 J = 2 Hz, 2 H), 6.15 (t, 4 J = 2 Hz, 1 H), 7.25-7.31 (m, 7 H), 7.68 (d, 3 J = 8.5 Hz, 2 H). 13C NMR (75 MHz, CDCl3): δ = 21.71 (q), 70.28 (t), 115.87 (d), 127.13 (s), 127.79 (d), 128.48 (d), 128.54 (d), 129.57 (d), 134.49 (s), 134.80 (s), 145.76 (s), 153.90 (s, C=O). IR (ATR): 3058 (w, C=CR), 1788 (ss, C=O) cm-1. MS (DIP-EI, 70 eV): m/z (%) = 329 [M+], 174 (12), 155 (33), 130 (68), 103 (25), 91 (100), 77 (26), 65 (31), 51 (9). HRMS (EI): m/z [M]+ calcd for 12C17H15 14N16O4 32S: 321.0721; found: 321.072.
4-Methylene-3-phenyloxazolidin-2-one ( 9d): 1H NMR (250 MHz, CDCl3): δ = 4.12 (d, 2 J = 2.5 Hz, 1 H, C=CH), 4.21 (d, 2 J = 2.5 Hz, 1 H, C=CH), 5.01 (t, 2 J = 2 Hz, 2 H), 7.30-7.46 (m, 5 H). 13C NMR (75 MHz, CDCl3): δ = 67.10 (t), 82.00 (t), 126.91 (d), 128.94 (d), 129.15 (d), 133.55 (s), 141.72 (s), 155.97 (s, C=O). IR (ATR): 1757 (ss, C=O), 1680 (s, C=CH) cm-1. MS (DIP-EI, 70 eV): m/z (%) = 175 [M+], 130 (100), 103 (56), 91 (8), 77 (68), 63 (10), 51 (46). HRMS (EI): m/z [M]+ calcd for 12C10H9 14N16O2: 175.0633; found: 175.063.
( Z )-4-Ethylidene-3-phenyloxazolidin-2-one ( 9e): 1H NMR (250 MHz, CDCl3): δ = 1.06 (td, 5 J = 2.3 Hz, 3 J = 7.3 Hz, 3 H), 4.47 (tq, 4 J = 2.3 Hz, 3 J = 7.3 Hz, 1 H), 4.91 (m, 2 H), 7.30-7.43 (m, 5 H). 13C NMR (75 MHz, CDCl3): δ = 10.43 (q), 66.06 (t), 93.17 (d), 127.09 (d), 127.17 (d), 128.21 (d), 128.59 (d), 129.55 (d), 129.87 (d), 130.59 (s), 135.16 (s). IR (ATR): 1771 (ss, C=O), 1699 (s, C=CH) cm-1. MS (DIP-EI, 70 eV): m/z (%) = 207 [M+], 189 (32), 149 (33), 132 (36), 119 (100), 104 (27), 91 (29), 84 (74), 77 (69), 57 (77), 49 (94). HRMS (EI): m/z [M]+ calcd for 12C11H11 14N16O2: 189.079; found: 189.079.
( Z )-4-Benzylidene-3-phenyloxazolidin-2-one ( 9f): 1H NMR (300 MHz, CDCl3): δ = 5.10 (d, 4 J = 2.1 Hz, 2 H), 5.67 (s, 1 H), 6.63 (d, J = 1.7 Hz, 2 H), 6.81-6.90 (m, 3 H), 6.98-7.06 (m, 5 H). 13C NMR (75 MHz, CDCl3): δ = 68.03 (t), 99.89 (t), 125.88 (d), 126.96 (d), 128.12 (d), 128.16 (d), 128.68 (d), 129.74 (d), 132.27 (s), 132.83 (s), 134.60 (s), 156.95 (s, C=O). IR (ATR): 3053 (w, C=CR), 1769 (ss, C=O) cm-1. MS (DIP-EI, 70 eV): m/z (%) = 251 [M+], 206 (23), 104 (100), 89 (9), 77 (32), 63 (8), 51 (22). HRMS (EI): m/z [M]+ calcd for 12C16H13 14N16O2: 251.0946; found: 251.094.